Skip to content

To study the effect of Gruta Bhrusta Shabarak Lodhra Bidalak on Vataj Abhishyand

ASSESSMENT OF EFFICIENCY OF GHRUTA BHRUSTA SHABARAK LODHRA BIDALAKA IN VATAJ ABHISHYANDA RANDOMISED CONTROLLED TRIAL - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092571
Enrollment
80
Registered
2025-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H101- Acute atopic conjunctivitis

Interventions

None listed

Sponsors

PMTs Ayurveda College , Shevgaon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Paitents with signs and symptoms of Vataj Abhishyand like Toda, Sangharsh, Shishirashruta, Alpashopha, Shirobhitapa. Irrespective of their sex,race religion and economic status barrier.

Exclusion criteria

Exclusion criteria: Abhishyanda associated with other occular and systemic diseases. Patient having known case of HbsAg and HIV. Paitent having any corneal involvement like corneal opacity, corneal ulcer. One Eyed patient and patient recently operated for eye disease. Paitent having any adverse drug reaction.

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Ghruta Bhrusta Shabarak Lodhra Bidalak in Vataj Abhishyand Is there any reduction in symptoms or frequency of symptoms of Vataj Abhishyand ( Acute allergic conjunctivitis) that will be assessed after 15 daysTimepoint: 15 days treatment with 6 follow up 0, 3, 6, 9, 12, 15th day

Secondary

MeasureTime frame
To review the ayurvedic literature regarding Vataj Abhishyand. To review information about Bidalak kalpana in details. To review the modern literature regarding simple allergic conjunctivitis. To evaluate effect of Gruta Bhrusta Haritaki Bidalak. To evaluate effect of Gruta Bhrusta Shabarak Lodhra Bidalak with Ghruta Bhrusta Haritaki Bidalak in Vataj Abhishyand. To observe any adverse drug reactionTimepoint: 15 days treatment with 6 follow up 0, 3, 6, 9, 12, 15th day

Countries

India

Contacts

Public ContactDr Mahesh Dolas

PMTs Ayurveda College, Shevgaon

maheshdolas23@gmail.com8550991815

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026